5:44 PM
Jun 12, 2013
 |  BC Extra  |  Clinical News

VA researchers recommend delaying use of Enbrel for RA

Researchers at the Department of Veterans Affairs published a study that they said suggests a strategy of first administering a triple therapy of generics to treat adults with active rheumatoid arthritis (RA) before switching to a regimen with once-weekly Enbrel etanercept from Amgen Inc. (NASDAQ:AMGN) and Pfizer Inc. (NYSE:PFE). The researchers said the strategy -- where patients who do not have an adequate response to triple therapy would switch to Enbrel plus methotrexate...

Read the full 360 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >